StoryCommercial
Rezdiffra commercial launch in the United States
Madrigal PharmaceuticalsRezdiffra
Madrigal began commercial launch of Rezdiffra in April 2024, marking the first patient access to an approved MASH therapy in the United States. The company established a commercial infrastructure for patient education, insurance navigation and physician engagement.